Related Experiment Videos
A priori risk and optimal test accuracy in prenatal diagnostics
Stefan Felder1, Andreas Werblow, Bernt-Peter Robra
1Faculties of Medicine and Economics, Institute for Social Medicine and Health Economics, Otto-von-Guericke University, Magdeburg, Germany. stefan.felder@medizin.uni-madgeburg.de
Summary
The triple test effectively screens for fetal chromosome anomalies, reducing invasive procedures. Optimizing its cutoff risk balances detecting affected fetuses against false positives and negatives, improving prenatal screening accuracy.
Area of Science:
- Prenatal diagnostics
- Maternal-fetal medicine
- Biochemical screening
Background:
- Fetal chromosome anomaly risk increases with maternal age.
- Biochemical screening tests, like the triple test, aid in risk assessment.
- Current practice often mandates amniocentesis at maternal age 35, irrespective of screening results.
Purpose of the Study:
- To evaluate the tradeoff between false positives and false negatives in the triple test.
- To determine the optimal cutoff risk for the triple test.
- To analyze how factors like a-priori risk and miscarriage risk influence optimal test parameters.
Main Methods:
- Decision-analytic modeling was employed.
- The model evaluated the implicit tradeoff in current policy recommendations.
- Comparative static analysis was used to derive optimal cutoff levels.
Main Results:
- The optimal cutoff risk for the triple test was determined.
- Optimal test accuracy decreases with higher a-priori risk.
- Optimal test accuracy increases with higher miscarriage risk and maternal preference for detecting fetal anomalies.
Conclusions:
- The study provides a framework for optimizing the triple test's cutoff risk.
- Findings suggest current clinical practice regarding fixed cutoffs may not be optimal.
- Personalized risk assessment and test parameter optimization are crucial for improved prenatal screening outcomes.